← Back to all trials
Not Yet Recruiting
NCT05646888
Inflammation, Platelets and Sickle Cell Disease
Conditions: Platelet Activation, Thromboinflammation, Sickle Cell Disease
Sex: All
Ages: 18 Years – 99 Years
Enrollment: 10
Sponsor: University Hospital, Toulouse
Location: France
Summary
Sickle cell disease (SCD) is an autosomal recessive genetic disorder linked to a single mutation on beta-globin chains.
This leads to red blood cell deformation and chronic hemolysis which can result in vaso-occlusive events, anemia and vasculopathy.
Pathophysiology is incompletely understood, and beyond red blood cell's abnormalities this involves hemostasis and innate immunity.
The aim of our study is to describe the mechanisms of thrombo-inflammation during the vaso-occlusive crisis (VOC) in adults with sickle cell disease.
Eligibility Criteria
Inclusion Criteria:Patient with sickle cell disease diagnosis, hospitalized in emergency department and/or internal medicine departmentPatient older than 18 yearsWritten consent to participate to the studyPatient with health insurancePatient able to receive information about the studyExclusion Criteria:Age < 18 yearsNon consent to participate to the studyWomen in pregnancy or breastfeedingTreatment with aspirin or non steroidal anti inflammatory drugProtected patientPatient already involved in a study requiring collection of additional biological samples
Source: ClinicalTrials.gov (NCT05646888). StuddyBuddy aggregates publicly available trial information.